Influence of daunorubicin on membrane permeability properties: detection by means of intracellular accumulation and efflux of fluorescein.
The influence of daunorubicin (DNR) on membrane permeability properties was assessed by studying the ability of living HeLa cells to exhibit fluorochromasia; that is, to take up a fluorogenic substrate and retain the fluorescent compound obtained by enzymatic reaction. The intracellular accumulation of the fluorescent product as well as its release by the cells may be considered indicators of the permeability properties, since both processes are mediated by the cell membrane. The influence of the drug on the accumulation and on the efflux of fluorescein, obtained intracellularly from the hydrolysis of fluorescein diacetate (FDA), was evaluated, after DNR treatment, by measuring the fluorescence intensity of the product in single living cells by flow cytometry. The results showed that DNR, up to a concentration of 5 X 10(-6) M, did not significantly affect the accumulation of fluorescein. On the contrary, the efflux was strongly inhibited. A comparative study of the influence of drugs with known action mechanism was performed with the membrane-active compound hydrocortisone (HC) and with the metabolic inhibitor KCN. The results obtained indicate that DNR significantly affects membrane permeability properties and that its influence is similar to that exerted by metabolic inhibitors.
D002463:Cell Membrane Permeability / Q000187:drug effects*; D003630:Daunorubicin / Q000494:pharmacology*; D005434:Flow Cytometry / Q000379:methods; D005452:Fluoresceins / Q000378:metabolism; D006367:HeLa Cells / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D011190:Potassium Cyanide / Q000494:pharmacology
D005452:Fluoresceins; D011190:Potassium Cyanide; C018506:diacetylfluorescein; D003630:Daunorubicin